Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1263400-52-7

3-(2-chloropyridin-4-yl)oxetan-3-ol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1263400-52-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1263400-52-7 Structure

  • Basic information

    1. Product Name: 3-(2-chloropyridin-4-yl)oxetan-3-ol
    2. Synonyms: 3-(2-chloropyridin-4-yl)oxetan-3-ol
    3. CAS NO:1263400-52-7
    4. Molecular Formula: C8H8ClNO2
    5. Molecular Weight: 185.60762
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1263400-52-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-(2-chloropyridin-4-yl)oxetan-3-ol(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-(2-chloropyridin-4-yl)oxetan-3-ol(1263400-52-7)
    11. EPA Substance Registry System: 3-(2-chloropyridin-4-yl)oxetan-3-ol(1263400-52-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1263400-52-7(Hazardous Substances Data)

1263400-52-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1263400-52-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,3,4,0 and 0 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1263400-52:
(9*1)+(8*2)+(7*6)+(6*3)+(5*4)+(4*0)+(3*0)+(2*5)+(1*2)=117
117 % 10 = 7
So 1263400-52-7 is a valid CAS Registry Number.

1263400-52-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(2-chloropyridin-4-yl)oxetan-3-ol

1.2 Other means of identification

Product number -
Other names 3-(2-chloropyridin-4-yl)oxetan-3-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1263400-52-7 SDS

1263400-52-7Relevant articles and documents

BTK INHIBITORS

-

Page/Page column 148; 149, (2014/08/07)

The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.

BTK INHIBITORS

-

Paragraph 0851, (2014/08/06)

The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.

BTK INHIBITORS

-

Page/Page column 105, (2014/08/07)

The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I) or pharmaceutically acceptable salts thereof. (Formula I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.

4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors

-

Paragraph 0224, (2013/03/26)

The present invention provides 6-5 membered fused pyridine ring compounds according to Formula I or pharmaceutically acceptable salts thereof. or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.

2, 7 -NAPHTHYRIDIN- 1 -ONE DERIVATIVES AS SYK KINASE INHIBITORS

-

Page/Page column 112, (2011/02/24)

Provided herein area novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1263400-52-7